OBJECTIVE: To study screening outcomes among a group of Tibetan immigrants at high risk for developing active tuberculosis (TB) after arrival in Minnesota. DESIGN: Retrospective cohort study. PARTICIPANTS: A total of 191 Tibetan immigrants undergoing medical screening. MAIN OUTCOME MEASURES: Occurrence and treatment outcomes of active TB. SETTING: A health maintenance organization and a public TB clinic in Minneapolis, Minn. RESULTS: Positive (induration, > or =10 mm) tuberculin skin test results were documented in 98% of Tibetans, compared with 44% of Vietnamese, 10% of Hmong, and 51% of Russian refugees in Minnesota (P<.001 for each group). Sixteen active cases (8.4%) were confirmed by isolation of Mycobacterium tuberculosis; however, 5 (31%) were culture-negative on initial screening in Minnesota. Seven cases (44%) were diagnosed during initial screening efforts, and 9 cases (56%) were diagnosed a mean of 19 months (range, 10-27 months) after their initial medical evaluation. Of these 9 cases, 6 (38% of all Tibetan cases) had isolates resistant to 1 or more antituberculous drugs, and 3 (19% of all Tibetan cases) were multidrug resistant (MDR TB). All 3 MDR TB cases were culture-negative on initial screening; these cases constituted 75% of the MDR TB isolates in Minnesota in 1994. The presence of MDR TB was associated with a known history of active TB in Asia (P<.02). Any abnormality on chest radiograph noted either during the Immigration and Naturalization Service screening evaluation in India (relative risk [RR], 5.2; P=.006) or on arrival in Minnesota (RR, 6.8; P=.005) was associated with an increased risk of subsequent active TB. CONCLUSIONS: Tuberculosis infection is nearly universal among Tibetans settling in Minnesota. A single screening evaluation failed to detect the majority of TB cases among Tibetans. Even in the face of negative M tuberculosis cultures, persons with a history of active TB require particularly close follow-up.
OBJECTIVE: To study screening outcomes among a group of Tibetan immigrants at high risk for developing active tuberculosis (TB) after arrival in Minnesota. DESIGN: Retrospective cohort study. PARTICIPANTS: A total of 191 Tibetan immigrants undergoing medical screening. MAIN OUTCOME MEASURES: Occurrence and treatment outcomes of active TB. SETTING: A health maintenance organization and a public TB clinic in Minneapolis, Minn. RESULTS: Positive (induration, > or =10 mm) tuberculin skin test results were documented in 98% of Tibetans, compared with 44% of Vietnamese, 10% of Hmong, and 51% of Russian refugees in Minnesota (P<.001 for each group). Sixteen active cases (8.4%) were confirmed by isolation of Mycobacterium tuberculosis; however, 5 (31%) were culture-negative on initial screening in Minnesota. Seven cases (44%) were diagnosed during initial screening efforts, and 9 cases (56%) were diagnosed a mean of 19 months (range, 10-27 months) after their initial medical evaluation. Of these 9 cases, 6 (38% of all Tibetan cases) had isolates resistant to 1 or more antituberculous drugs, and 3 (19% of all Tibetan cases) were multidrug resistant (MDR TB). All 3 MDR TB cases were culture-negative on initial screening; these cases constituted 75% of the MDR TB isolates in Minnesota in 1994. The presence of MDR TB was associated with a known history of active TB in Asia (P<.02). Any abnormality on chest radiograph noted either during the Immigration and Naturalization Service screening evaluation in India (relative risk [RR], 5.2; P=.006) or on arrival in Minnesota (RR, 6.8; P=.005) was associated with an increased risk of subsequent active TB. CONCLUSIONS:Tuberculosis infection is nearly universal among Tibetans settling in Minnesota. A single screening evaluation failed to detect the majority of TB cases among Tibetans. Even in the face of negative M tuberculosis cultures, persons with a history of active TB require particularly close follow-up.
Authors: Jonathon R Campbell; Wenjia Chen; James Johnston; Victoria Cook; Kevin Elwood; Jane Krot; Fawziah Marra Journal: Mol Diagn Ther Date: 2015-04 Impact factor: 4.074
Authors: Amod K Pokhrel; Michael N Bates; Sharat C Verma; Hari S Joshi; Chandrashekhar T Sreeramareddy; Kirk R Smith Journal: Environ Health Perspect Date: 2010-04 Impact factor: 9.031
Authors: Kevin P Cain; Nina Marano; Maureen Kamene; Joseph Sitienei; Subroto Mukherjee; Aleksandar Galev; John Burton; Orkhan Nasibov; Jackson Kioko; Kevin M De Cock Journal: PLoS Med Date: 2015-02-24 Impact factor: 11.069
Authors: John E Oeltmann; Jay K Varma; Luis Ortega; Yecai Liu; Thomas O'Rourke; Maria Cano; Theresa Harrington; Sean Toney; Warren Jones; Samart Karuchit; Lois Diem; Dhanida Rienthong; Jordan W Tappero; Kashef Ijaz; Susan A Maloney Journal: Emerg Infect Dis Date: 2008-11 Impact factor: 6.883